Hospira Defeats Class Action Over Drug Shortage

Law360, New York (July 2, 2012, 5:08 PM EDT) -- Hospira Inc. was within its rights to halt production of an injectable vitamin supplement, a federal judge said Monday in wiping out a proposed class action brought by a Florida woman who says she’s going blind because the treatment isn’t available.

Jennifer Lacognata sued the pharmaceutical company in April over shortages of a vitamin A medicine known as Aquasol A, which Hospira stopped producing in 2010. But there’s no basis for the case, as it would improperly intrude on Hospira’s business prerogatives, U.S. District Judge James...
To view the full article, register now.